The use of prophylactic somatostatin therapy following pancreaticoduodenectomy: a meta-analysis of randomised controlled trials
Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials.
A Adiamah, Z Arif, F Berti, S Singh, N Laskar… - World Journal of …, 2019 - europepmc.org
Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials
A Adiamah, Z Arif, F Berti, S Singh… - World journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta‐analysis of Randomised Controlled Trials
A Adiamah, Z Arif, F Berti, S Singh… - World Journal of …, 2019 - Wiley Online Library
Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post‐operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post‐operative pancreatic fistula (POPF) remains contentious. This meta …
The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials
A Adiamah, Z Arif, F Berti, S Singh… - World Journal of …, 2019 - search.proquest.com
Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials
A Adiamah, Z Arif, F Berti, S Singh, N Laskar… - World Journal of …, 2019 - infona.pl
Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials.
A Adiamah, Z Arif, F Berti, S Singh… - World Journal of …, 2019 - search.ebscohost.com
Background: Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials
A Adiamah, Z Arif, F Berti, S Singh, N Laskar… - World Journal of …, 2019 - infona.pl
Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …